Mydecine Innovations Group Inc. provided a corporate update regarding recent advancements and achievements that continues to add shareholder value and position Mydecine as a genuine leader in the ever-expanding fungi and psychedelic sectors. Appointed Damon Michaels, a driven thought leader with a 15+ year track record of executing growth strategies with large innovative companies to the role of Chief Operations Officer; Appointed Rob Roscow, an accomplished scientist with a foundation and keen interest in genetic engineering to the role of Chief Science Officer; Appointed previous Red Bull Marketing Executive and experienced brand builder, Jim Gunning to role of Chief Marketing Officer. Appointed to Dr. Denton Hoyer, former Pfizer researcher and Director of Chemistry for the Yale Center for Molecular Discovery, the Scientific Advisory Board. Appointed Vince Polito and Anton Gomez-Escolar as advisors to lead psilocybin microdosing research and development; Appointed Dr. Mali Reddy (M.S. Reddy) seven-time Nobel Prize Nominee and the "Godfather of Pro-Biotics" to the Scientific Advisory board; Appointed Dr. Aubrey Oliver to Advisory board to spearhead the company’s expansion into Jamaica, one of the only legal psilocybin markets in the world.